Early- and Long-Term Outcomes of Mitral Valve Repair in a Low-Volume Centre in the Caribbean

Richard A E Ramsingh1,2, Gianni D Angelini3, Risshi D Rampersad1

  • 1Cardiology Department, Caribbean Heart Care Medcorp, St. Clair Medical Centre, St. Clair, Port of Spain, Trinidad & Tobago.

Insights

Mitral valve repair in a low-volume Caribbean center showed good early and long-term outcomes. Despite challenges, the procedure is safe and effective for both functional (FMR) and degenerative (DMR) mitral regurgitation.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Valve Repair
  • Outcomes Research

Background:

  • Mitral valve repair is a complex procedure often associated with high-volume centers.
  • Low-volume centers face unique challenges in maintaining surgical expertise and achieving optimal patient outcomes.

Purpose of the Study:

  • To evaluate the early and long-term results of mitral valve repair in a low-volume cardiac surgery center in the Caribbean.
  • To assess the safety and efficacy of mitral valve repair for functional mitral regurgitation (FMR) and degenerative mitral regurgitation (DMR).

Main Methods:

  • Retrospective analysis of prospectively collected data from 96 consecutive mitral valve repair patients (April 2009-December 2018).
  • Patients were categorized into FMR (n=63) and DMR (n=33) groups based on repair complexity.
  • Outcomes assessed included 30-day mortality, early and late echocardiographic results, functional status (NYHA class), re-operation rates, and survival.

Main Results:

  • Overall 30-day mortality was 2.1%. FMR group: 83.6% had no or trivial/mild regurgitation early post-op, but long-term functional status declined (42.8% NYHA class I). Survival was 75.6% with 98% freedom from re-operation.
  • DMR group: 97% had no or trivial/mild regurgitation early post-op, with sustained good long-term function (93.3% NYHA class I). Survival was 90.9% with no re-interventions and 96.3% mild or no mitral regurgitation.

Conclusions:

  • Mitral valve repair can be performed safely and effectively in low-volume centers, even with limited resources.
  • Good early and long-term outcomes are achievable for both FMR and DMR, highlighting the importance of dedicated surgical teams.
  • These findings support the feasibility of mitral valve repair in underserved regions, challenging the notion that it's exclusively confined to high-volume institutions.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
63
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
71
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
100
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
102
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
112
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
105